Management of Specialty Therapies in Today’s Complex Supply Chain – An Expert Discussion

With more specialty medicines coming to market, the care coordination and financial management associated with high-value therapies is increasing in complexity. Cell and gene therapies have ushered in a new era where treatments are patient specific. At the same time, the financial management for these therapies is creating new paradigms for sites of care and biopharma sponsors. Experts from Cardinal Health 3PL Services and Vineti discuss the considerations and preparations to help build a successful commercialization strategy and address the needs of stakeholders at sites of care and patients.